Implications of IDH mutations on immunotherapeutic strategies for malignant glioma

by Choi, B.D, Curry, W.T, Kitagawa, Y., Miller, J.J, Richardson, L.G, Wakimoto, H.
Published 2022

Measurement of Full Diffusion Tensor Distribution Using High-Gradient Diffusion MRI and Applications in Diffuse Gliomas

by Curry, W.T, Dietrich, J., Fan, Q., Forst, D.A, Gerstner, E.R, Huang, S.Y, Ly, I., Martinez-Lage, M., Nummenmaa, A., Rosen, B.R, Song, Y.
Published 2022

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

by Patel, A. P., Tirosh, I., Trombetta, J. J., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., Louis, D. N., Rozenblatt-Rosen, O., Suva, M. L., Bernstein, Bradley E., Regev, Aviv, Shalek, Alex K.
Published 2015

Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas

by Wakimoto, H., Tanaka, S., Curry, W. T., Loebel, F., Zhao, D., Tateishi, K., Chen, J., Klofas, L. K., Lelic, N., Kim, J. C., Dias-Santagata, D., Ellisen, L. W., Borger, D. R., Fendt, Sarah-Maria, Batchelor, Tracy T., Iafrate, A. John, Cahill, D. P., Chi, A. S., Vander Heiden, Matthew G.
Published 2015